|
2025
|
Invention
|
Genetically modified nk-92 cell line.
This invention is directed to treatment of a subject havin... |
|
|
Invention
|
Inhibitors of ripk3 and methods of use thereof. Disclosed herein are compounds and derivatives th... |
|
|
Invention
|
Compositions and methods for treating cancer with calcium channel inhibitors.
Disclosed are meth... |
|
|
Invention
|
Antibodies to cell adhesion molecule-related/down-regulated by oncogenes (cdon) and uses thereof.... |
|
2024
|
Invention
|
Kinase activity in tumors.
The present disclosure provides a multi-analyte column comprising at ... |
|
|
Invention
|
Methods and compositions for increasing ror1 expression. Disclosed are methods of increasing R0R1... |
|
|
Invention
|
Frequent egfr and ntrk somatic mutations in colorectal cancer (crc) with microsatellite instabili... |
|
|
Invention
|
Compositions and methods for the treatment of cancers by triggering anti-viral response. Composit... |
|
|
Invention
|
Prodigiosin analogs and methods of use. Prodigiosin analogs which reactivate the p53 pathway are ... |
|
|
Invention
|
Methods of degrading raf(raf) protein in cells using mitogen-activated protein kinase kinase 1/2 ... |
|
2023
|
Invention
|
Tensionable surgical clamp. The present disclosure provides surgical clamps. The clamp has a body... |
|
|
Invention
|
Combination therapies for treating cancer. Pharmaceutical compositions comprising a combination o... |
|
|
Invention
|
Treatment of tumors with mirna targeting cdk4/cdk6.
The present disclosure provides miRNA mimics... |
|
|
Invention
|
Mixed lineage kinase domain like pseudokinase (mlkl) activators. Disclosed are substituted, heter... |
|
|
Invention
|
Methods of treating cancer with transmembrane protein 16f (tmem16f) inhibitors.
Compositions com... |
|
|
Invention
|
Methods of treating medulloblastoma with thyroid hormone. The present disclosure provides methods... |
|
|
Invention
|
Genetically modified human natural killer cell lines.
The invention provides a natural killer ce... |
|
|
Invention
|
Computationally engineered monocolonal antibodies and antigen binding fragments specific for sars... |
|
|
Invention
|
Pak1 degraders and methods of use thereof.
PAK1 degraders and methods of use thereof are disclosed. |
|
|
Invention
|
Pak1 degraders and methods of use thereof. PAK1 degraders and methods of use thereof are disclosed. |
|
|
Invention
|
Combination of curaxins and immune checkpoint inhibitors for treating cancer.
The present disclo... |
|
|
Invention
|
Set domain-containing 2 (setd2) vaccine.
Pharmaceutical compositions comprising one or more pept... |
|
|
Invention
|
Set domain-containing 2 (setd2) vaccine. Pharmaceutical compositions comprising one or more pepti... |
|
|
Invention
|
Combination of curaxins and immune checkpoint inhibitors for treating cancer. The present disclos... |
|
|
Invention
|
Mir-3132 upregulation of the trail pathway and apoptotic activity in cancer cells. The present di... |
|
2022
|
Invention
|
Combination therapy for cancer treatment.
Pharmaceutical compositions comprising: one or more PR... |
|
|
Invention
|
Combination therapy for cancer treatment. Pharmaceutical compositions comprising: one or more PRO... |
|
|
Invention
|
Compositions and methods for regulating egfr amplification in cancer cells for improving efficacy... |
|
|
Invention
|
Malignant mesothelioma susceptibility as a result of germline leucine-rich repeat kinase 2 (lrrk2... |
|
|
Invention
|
Rna virus vectors carrying dai and ripk3.
RNA virus vectors comprising a gene encoding the DNA-d... |
|
|
Invention
|
Compositions and methods for modulation of antibody activity. Compositions and methods for modula... |
|
|
Invention
|
Treatment of integrin-related disorders with stapled peptides.
The present disclosure provides, ... |
|
|
Invention
|
Treatment of integrin-related disorders with stapled peptides. The present disclosure provides, i... |
|
2021
|
Invention
|
Treatment of females having brca1/2 mutations with human chorionic gonadotropin to reduce the ris... |
|
|
Invention
|
Treatment of non-alcoholic steatohepatitis (nash) with il-27 antibody. The present disclosure pro... |
|
|
Invention
|
Methods of treating cancer.
Phenylsulfonamido compounds that inhibit genome-wide hypomethylation... |
|
|
Invention
|
Exosome analysis and brain tumors.
The present disclosure provides methods of diagnosing, preven... |
|
|
Invention
|
Bronchoscope tip marker for orientation of radial endobronchial ultrasound probe. A radial endobr... |
|
|
Invention
|
Estrogen metabolite levels and cancer driver gene mutations in lung cancer risk stratification an... |
|
2020
|
Invention
|
Combination therapy for treatment of cancer.
Pharmaceutical compositions comprising: one or more... |
|
|
Invention
|
Adeno-associated virus vector delivery of cystathionine beta-synthase (cbs) enzyme for treating c... |
|
|
Invention
|
Pi3k/lyn-acly signaling inhibition.
The present disclosure is directed, in part, to pharmaceutic... |
|
|
Invention
|
Netrin g1 and netrin g1 ligand peptides and antibodies and uses thereof.
The present disclosure ... |
|
2017
|
Invention
|
Active alpha-5-beta-1 integrin as a biomarker for enhancing tumor treatment efficacy.
Methods fo... |
